Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Cancer Discovery

Topics

Medicine

Cancer Oncology

Internal Medicine

Pulmonary And Respiratory Medicine

Palbociclib

Show all topics

DOI

10.1158/2159-8290.cd-16-0095